Skip to main content

Table 2 Clinical and pathological characteristics of breast cancers

From: Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study

Classification

N (%)

Pathology

 Ductal

1289 (74.3)

 Lobular

112 (6.5)

 Papilar

22 (1.3)

 Coloid

20 (1.2)

 Tubular

12 (0.7)

 Mixed

27 (1.6)

 Other

35 (2.0)

 Not Available

213 (12.3)

Clinical stage

 0

115 (6.6)

 I

604 (34.8)

 II

495 (28.5)

 III

182 (10.5)

 IV

22 (1.3)

 Not Available

196 (11.3)

Inmunohistochemistry

 Progesterone

992 (62.5)

 Estrogens

1147 (72.2)

 HER2

227 (14.3)

 Triple negative

92 (5.8)